Pseudohypoaldosteronism (PHA) type II from with-no-lysine kinase 4 (WNK-4) mutation can cause hypercalciuria from its role in regulation of TRPV5, whereas dRTA leads to hypercalciuria indirectly from metabolic acidosis and increased bone resorption. This evidence concerns the gene WNK4 and Hypercalciuria.